These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 9282935

  • 21. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.
    Mang CF, Erbelding D, Kilbinger H.
    Br J Pharmacol; 2001 Sep; 134(1):161-7. PubMed ID: 11522608
    [Abstract] [Full Text] [Related]

  • 22. Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens.
    Pertwee RG, Joe-Adigwe G, Hawksworth GM.
    Eur J Pharmacol; 1996 Jan 25; 296(2):169-72. PubMed ID: 8838453
    [Abstract] [Full Text] [Related]

  • 23. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
    Cheer JF, Cadogan AK, Marsden CA, Fone KC, Kendall DA.
    Neuropharmacology; 1999 Apr 25; 38(4):533-41. PubMed ID: 10221757
    [Abstract] [Full Text] [Related]

  • 24. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP, Howlett AC.
    Neuropharmacology; 2001 Jun 25; 40(7):918-26. PubMed ID: 11378162
    [Abstract] [Full Text] [Related]

  • 25. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A, Wilhelm A, Simmet T.
    Br J Pharmacol; 1999 Apr 25; 126(8):1831-9. PubMed ID: 10372827
    [Abstract] [Full Text] [Related]

  • 26. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA, Járai Z, Bátkai S, Kunos G.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):203-10. PubMed ID: 11448486
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F, Molina-Holgado E, Guaza C, Rothwell NJ.
    J Neurosci Res; 2002 Mar 15; 67(6):829-36. PubMed ID: 11891798
    [Abstract] [Full Text] [Related]

  • 29. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC, Martin BR, Ellis EF.
    Biochem Pharmacol; 1996 Mar 08; 51(5):669-76. PubMed ID: 8615904
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH, Oriowo MA.
    Pharmacol Res; 1999 Nov 08; 40(5):415-21. PubMed ID: 10527656
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
    Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D.
    Eur J Pharmacol; 1997 Dec 11; 340(2-3):R7-8. PubMed ID: 9537804
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF, Hillard CJ, Edgemond WS, Campbell WB.
    Am J Physiol; 1998 Jan 11; 274(1):H375-81. PubMed ID: 9458889
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G, Lovinger DM.
    J Neurophysiol; 2001 Jan 11; 85(1):468-71. PubMed ID: 11152748
    [Abstract] [Full Text] [Related]

  • 36. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS, Cornish JL, Mallet PE, McGregor IS.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):105-14. PubMed ID: 12650839
    [Abstract] [Full Text] [Related]

  • 37. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D, Thayer SA.
    J Neurosci; 2001 May 15; 21(10):RC146. PubMed ID: 11319244
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.
    Szabo B, Dörner L, Pfreundtner C, Nörenberg W, Starke K.
    Neuroscience; 1998 Jul 15; 85(2):395-403. PubMed ID: 9622239
    [Abstract] [Full Text] [Related]

  • 39. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14136-41. PubMed ID: 10570211
    [Abstract] [Full Text] [Related]

  • 40. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.